Examining the Controversy Surrounding Alcohol Promotion in Oncology Events: Virtue Signaling or Cancer Advocacy?
By Shaalan Beg, MD, MBA, FASCO, and Noelle K. LoConte, MD, FASCOShould oncology organizations and cancer centers allocate funds to serve and therefore promote the consumption of alcohol, a known carcinogen? According to a recent poll on social media, only approximately one-third of respondents believe they should.1 This topic has sparked numerous discussions, and these...
By Fernando Diaz, MD, Anahid Hamparsumian, MD, Melisa L. Wong, MD, MAS, and Grant R. Williams, MD, MPHBy 2030, it is projected that 70% of all cancer diagnoses will occur in older adults.1 Despite the increased incidence of cancer in this age group, older adults are traditionally under-represented in clinical trials and outcome measures...
The relative newcomer to the field, ripretinib, was compared to standard second-line treatment with sunitinib in patients with advanced gastrointestinal stromal tumors. Medscape Medical News
Findings from this phase 2 trial support further study of erlotinib as "an effective, acceptable cancer preventive agent for FAP-associated gastrointestinal polyposis," the study team says. Medscape Medical News
The US Multi-Society Task Force on Colorectal Cancer provides 14 recommendations for the genetic evaluation, surveillance, and treatment of gastrointestinal hamartomatous polyposis syndromes. Medscape Medical News
Compared with older White patients, Black patients with gastrointestinal cancer are about two times more likely to be frail and to report impairments performing daily activities. Medscape Medical News
A new analysis found that "Black patients are less likely than White patients to receive standard of care" when undergoing surgery to treat gastrointestinal tract cancer. Medscape Medical News
Obesity was associated with an increased risk of colon cancer in men and women, but this association varied for other gastrointestinal cancers. Medscape Medical News
Patients who develop upper gastrointestinal cancers within 3 years of esophagogastroduodenoscopy are less likely to present with 'alarm' symptoms than patients whose upper GI cancers are detected at endoscopy, according to new research. Reuters Health Information
Time Management Tips
15.7 ° C